WIN 34BAlternative Names: WIN-34B
Latest Information Update: 04 Dec 2015
At a glance
- Originator Hamsoa Pharmaceutical
- Class Analgesics; Anti-infectives; Anti-inflammatories; Herbal medicines
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Osteoarthritis